For FDA-approved GLP-1 and incretin-based medications, out-of-pocket cost can vary by brand, dose, pharmacy, insurance coverage, savings-card eligibility, approved indication, and program structure
The FDA permits compounding when patients cannot access FDA-approved alternatives due to allergies to inactive ingredients, need for a different dosage form (such as liquid instead of pills), or medication shortages
Dai for technical assistance, S
The distribution of the reported years exhibited a generally even pattern, with a noticeable upward trend observed in 2022
These are observational findings, not medical advice but they support keeping training progressions gradual and monitoring recovery metrics closely after starting treatment.
doi: 10.1053/j.gastro.2003.12.008